Approved Symbol |
Approved Name |
Location |
Source |
IL7R |
interleukin 7 receptor |
5p13 |
Mapped by significant region |
PRLR |
prolactin receptor |
5p14-p13 |
Mapped by significant region |
IL12B |
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
5q31.1-q33.1 |
Mapped by significant region |
IL10RA |
interleukin 10 receptor, alpha |
11q23 |
Mapped by significant region |
CCR5 |
chemokine (C-C motif) receptor 5 |
3p21 |
Mapped by PBA pathway |
IL18 |
interleukin 18 (interferon-gamma-inducing factor) |
11q22.2-q22.3 |
Mapped by significant region |
IL6 |
interleukin 6 (interferon, beta 2) |
7p21-p15 |
Mapped by significant region |
IL22RA2 |
interleukin 22 receptor, alpha 2 |
6q24.1-q24.2 |
Mapped by significant region |
RELT |
RELT tumor necrosis factor receptor |
11q13.2 |
Mapped by significant region |
CTF1 |
cardiotrophin 1 |
16p11.2 |
Mapped by CNV |
GHR |
growth hormone receptor |
5p14-p12 |
Mapped by CNV; Mapped by significant region |
IFNGR1 |
interferon gamma receptor 1 |
6q23-q24 |
Mapped by significant region |
LIFR |
leukemia inhibitory factor receptor alpha |
5p13-p12 |
Mapped by significant region |
CLCF1 |
cardiotrophin-like cytokine factor 1 |
11q13.3 |
Mapped by significant region |
TGFBR1 |
transforming growth factor, beta receptor 1 |
9q22 |
Mapped by significant region |
VEGFB |
vascular endothelial growth factor B |
11q13 |
Mapped by significant region |
CXCR2 |
chemokine (C-X-C motif) receptor 2 |
2q35 |
Mapped by significant region |
CXCR1 |
chemokine (C-X-C motif) receptor 1 |
2q35 |
Mapped by significant region |
CXCR5 |
chemokine (C-X-C motif) receptor 5 |
11q23.3 |
Mapped by significant region |
TNFSF18 |
tumor necrosis factor (ligand) superfamily, member 18 |
1q23 |
Mapped by significant region |
TNFRSF11A |
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
18q22.1 |
Mapped by CNV |
TNFSF15 |
tumor necrosis factor (ligand) superfamily, member 15 |
9q32 |
Mapped by significant region |
TNFRSF13B |
tumor necrosis factor receptor superfamily, member 13B |
17p11.2 |
Mapped by significant region |
EDA2R |
ectodysplasin A2 receptor |
Xq11.1 |
Mapped by CNV |
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8 |
9q33 |
Mapped by significant region |
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4 |
1q25 |
Mapped by significant region |
CCL27 |
chemokine (C-C motif) ligand 27 |
9p13 |
Mapped by LD-proxy |
CCL19 |
chemokine (C-C motif) ligand 19 |
9p13 |
Mapped by LD-proxy |
OSMR |
oncostatin M receptor |
5p13.2 |
Mapped by significant region |
IL5RA |
interleukin 5 receptor, alpha |
3p26-p24 |
Mapped by CNV |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
10q11.1 |
Mapped by PBA pathway |
IL11RA |
interleukin 11 receptor, alpha |
9p13 |
Mapped by LD-proxy |
FLT4 |
fms-related tyrosine kinase 4 |
5q34-q35 |
Mapped by CNV |